Amyloidosis Questions Answered: What Every Patient Should Know What is amyloidosis and why is it considered a rare disease? Amyloidosis […]

Cardiac Biomarkers in Amyloidosis: NT-proBNP, Troponin, and Beyond Introduction to Cardiac Biomarkers in Amyloidosis Cardiac involvement is one of the

Daily, Weekly, and Monthly Tracking: A Guide for Amyloidosis Patients Living with amyloidosis requires more than just attending medical appointments.

Monitoring TTR Silencer Therapy: A Patient-Friendly Checklist Introduction Hereditary transthyretin amyloidosis (ATTRv) and Wild-Type ATTR (ATTRwt) are progressive diseases that

Emergency Plans and Red Flags for Amyloidosis Patients Amyloidosis is a rare condition caused by abnormal protein deposits in organs

Daratumumab: The First FDA-Approved Treatment for AL Amyloidosis – A Complete Patient Guide AL amyloidosis is a rare and serious

Understanding Normal Kappa and Lambda Light Chain Levels: A Complete Patient Guide Introduction: Why Light Chains Matter Kappa and lambda

Understanding the Quality of Life Challenges Faced by AL Amyloidosis Patients Introduction AL amyloidosis is not just a medical condition;

The Role of Multidisciplinary Care in Improving Outcomes for AL Amyloidosis Introduction AL (Light Chain) Amyloidosis is a complicated and

Bispecific Antibodies in AL Amyloidosis: Introduction: Why Bispecifics Matter in AL Amyloidosis AL amyloidosis has long been one of the